Compare ARK Genomic Revolution ETF (ARKG) vs Diageo plc (DEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Diageo plc — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while Diageo plc trades at $94.44 (market cap $53.05B). The key difference: Diageo plc pays a 3.5% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Diageo plc nearer its low. Which is the better fit depends on your goals.
| ARKG | DEO | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $115.33 |
52-Week Low | $24.02 | $72.47 |
Market Cap | — | $53.05B |
Enterprise Value | — | $72.54B |
Dividend Yield | — | 3.5% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →
